- Home
- GH vs OMAB Comparison
GH vs OMAB Comparison
Compare GH & OMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- OMAB
- Stock Information
- Founded
- GH 2011
- OMAB 1998
- Country
- GH United States
- OMAB Mexico
- Employees
- GH N/A
- OMAB N/A
- Industry
- GH Medical Specialities
- OMAB Aerospace
- Sector
- GH Health Care
- OMAB Consumer Discretionary
- Exchange
- GH Nasdaq
- OMAB Nasdaq
- Market Cap
- GH 4.9B
- OMAB 4.8B
- IPO Year
- GH 2018
- OMAB 2006
- Fundamental
- Price
- GH $51.98
- OMAB $105.70
- Analyst Decision
- GH Strong Buy
- OMAB Buy
- Analyst Count
- GH 20
- OMAB 4
- Target Price
- GH $54.35
- OMAB $102.50
- AVG Volume (30 Days)
- GH 2.3M
- OMAB 62.5K
- Earning Date
- GH 08-06-2025
- OMAB 07-25-2025
- Dividend Yield
- GH N/A
- OMAB 3.77%
- EPS Growth
- GH N/A
- OMAB 2.49
- EPS
- GH N/A
- OMAB 0.65
- Revenue
- GH $773,996,000.00
- OMAB $728,352,552.00
- Revenue This Year
- GH $23.14
- OMAB $6.46
- Revenue Next Year
- GH $21.42
- OMAB $12.84
- P/E Ratio
- GH N/A
- OMAB $20.00
- Revenue Growth
- GH 28.20
- OMAB N/A
- 52 Week Low
- GH $20.14
- OMAB $59.08
- 52 Week High
- GH $53.42
- OMAB $108.23
- Technical
- Relative Strength Index (RSI)
- GH 63.61
- OMAB 55.05
- Support Level
- GH $47.45
- OMAB $99.14
- Resistance Level
- GH $51.15
- OMAB $104.19
- Average True Range (ATR)
- GH 2.29
- OMAB 2.32
- MACD
- GH 0.05
- OMAB -0.64
- Stochastic Oscillator
- GH 65.43
- OMAB 31.35
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.